Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Advances continue to be made in the management of breast cancer. Sentinel Lymph node biopsy is now considered the operation of choice for staging the axilla and Neoadjuvant chemotherapy is utilised more and more in the management of breast cancer in an attempt to downsize the cancer prior to surgery. It remains unclear as to the order in which these treatments should be performed, both having advantages and disadvantages. Current practice seems to favour sentinel lymph node biopsy prior to Neoadjuvant chemotherapy however there are a small number of studies suggesting sentinel lymph node biopsy is both safe and accurate post Neoadjuvant chemotherapy. © 2010 Rila Publications Ltd.


Journal article


Focus on Cancer Medicine

Publication Date





24 - 26